Avivagen Inc.
VIVXF
$0.00
$0.000.00%
OTC PK
| 07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 52.69% | 10.69% | 30.15% | 28.21% | -50.22% |
| Total Depreciation and Amortization | -74.68% | -29.81% | -27.75% | -32.60% | -31.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.75% | 146.80% | -43.49% | 30.00% | -14.08% |
| Change in Net Operating Assets | 66.30% | 163.84% | 17.67% | 55.67% | 212.31% |
| Cash from Operations | 106.03% | 106.61% | 71.07% | 50.96% | -20.18% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | 101.67% | 99.57% | -1.33% | 56.86% | -123.91% |
| Issuance of Common Stock | -100.00% | -98.98% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -105.77% | 85.03% | 18.22% | 57.46% | 1,128.32% |
| Cash from Financing | -140.86% | -104.30% | 20.58% | 401.90% | 142.16% |
| Foreign Exchange rate Adjustments | -106.06% | 125.00% | 102.94% | -102.40% | -15.38% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.00% | -101.37% | 58.00% | 87.47% | 28.59% |